Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001037614 | SCV001201038 | uncertain significance | Colorectal cancer, hereditary nonpolyposis, type 7 | 2024-06-27 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with arginine, which is basic and polar, at codon 463 of the MLH3 protein (p.Ser463Arg). This variant is present in population databases (rs138974583, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with MLH3-related conditions. ClinVar contains an entry for this variant (Variation ID: 836477). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Medical Cytogenetics and Molecular Genetics Laboratory, |
RCV001270225 | SCV001364356 | likely pathogenic | Premature ovarian failure | 2020-03-02 | criteria provided, single submitter | research | |
Ambry Genetics | RCV003321784 | SCV002699042 | uncertain significance | not specified | 2024-11-05 | criteria provided, single submitter | clinical testing | The p.S463R variant (also known as c.1387A>C), located in coding exon 1 of the MLH3 gene, results from an A to C substitution at nucleotide position 1387. The serine at codon 463 is replaced by arginine, an amino acid with dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Center for Genomic Medicine, |
RCV003321784 | SCV004027533 | uncertain significance | not specified | 2024-07-31 | criteria provided, single submitter | clinical testing |